
|
Mortality
Among Human Immunodeficiency Virus-Infected Patients with Cirrhosis
or Hepatocellular Carcinoma Due to Hepatitis C Virus in French Departments
of Internal Medicine/Infectious Diseases, in 1995 and 1997
[Cacoub P et al. CID 2001;32:1207]: This
is a report from France concerning two retrospective multicenter
cohort surveys that included 17,487 HIV infected patients during
1995 and 26,497 in 1997. The survey indicated a dramatic decrease
in AIDS-related annual mortality: 7.4% in 1995 down to 1.7% in 1997.
The prevalence of HCV among HIV-infected patients was about 17%.
The total deaths in 1997 was 543, including 459 (1.7%) attributed
to AIDS and 30 (0.13%) attributed to cirrhosis or hepatocellular
carcinoma. Unlike HIV, there was no decrease in mortality rates
for 1997 compared to 1995.
Comment: HCV
co-infection is obviously a hot topic at the present time, but there
are no guidelines for management. It seems clear that HCV progresses
more rapidly in the presence of HIV infection; it is unclear if
HCV co-infection has any important influence on the rate of HIV
progression. The major controversy concerns the indications for
HCV therapy, which now usually consists of PEG interferon combined
with ribavirin, but indications are often vague. According to the
data presented here, the annual death rate for HCV-related cirrhosis
and liver cancer were only 0.06% and 0.07% in 1995 and 1997, respectively.
posted 5/17/2001

|

|